ESC Premium Access

Reversal of the thrombin inhibitor dabigatran.

Presentation

About the speaker

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
6 presentations
0 follower

3 more presentations in this session

When should I use reversal agents for NOACs?

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Reversal of FXa inhibitors.

Speaker: Associate Professor S. Wassmann (Munich, DE)

Thumbnail

Will the availability of specific reversal agents change the use of NOACs?

Speaker: Professor F. Verheugt (Amsterdam, NL)

Thumbnail

Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Associate Professor A. Niessner, Professor G. Lip, Associate Professor S. Wassmann, Professor F. Verheugt
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Related content

ESC Premium Access

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

28 August 2021

This platform is supported by

logo Novo Nordisk